Use of NK-1 receptor antagonists for treating sexual dysfunction

The present invention provides a method for the treatment or prevention of sexual dysfunctions which comprises oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such an NK-1 receptor antagonist.

Saved in:
Bibliographic Details
Main Authors NADIA MELANIE RUPNIAK, JANUSZ JOZEF KULAGOWSKI, GREGORY JOHN HOLLINGWORTH, JASON MATTHEW ELLIOTT, NEIL ROY CURTIS, BRIAN JOHN WILLIAMS, EILEEN MARY SEWARD, CHRISTOPHER JOHN SWAIN, RAYMOND BAKER, TIMOTHY HARRISON, PHILIP STEPHEN JACKSON
Format Patent
LanguageEnglish
Published 29.03.2001
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a method for the treatment or prevention of sexual dysfunctions which comprises oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such an NK-1 receptor antagonist.
Bibliography:Application Number: AU5485898